Table 3.
Clinical characteristics of study patients with or without RAO at discharge
| Variable | All (n=118) | With RAO (n=9) | Without RAO (n=109) | P value |
|---|---|---|---|---|
| Age (years) | 64.5±10.4 | 64.4±7.32 | 64.5±10.6 | 0.987 |
| Men (n, %) | 79 (66.9%) | 6 (66.7%) | 73 (67.0%) | 0.985 |
| Height (m) | 1.66±10.2 | 1.68±8.25 | 1.66±10.3 | 0.571 |
| Weight (kg) | 69.5±12.2 | 72.9±15.2 | 69.3±12.0 | 0.395 |
| BMI (kg/m2) | 25.3±5.09 | 25.2±5.07 | 25.9±5.65 | 0.719 |
| Heparin dosage (U) | 3000 (3000–7000) | 3000 (3000–3000) | 5000(3000–7000) | 0.014 |
| Systolic BP (mmHg) | 131.6±23.1 | 128.2±20.1 | 131.9±23.4 | 0.650 |
| Diastolic BP (mmHg) | 75.2±9.46 | 77.7±12.2 | 75.0±9.23 | 0.420 |
| Diabetes mellitus (n, %) | 34 (29.1%) | 5 (55.6%) | 29 (26.9%) | 0.068 |
| Current smoking (n, %) | 10 (8.5%) | 0 (0.0%) | 10 (9.2%) | 0.342 |
| Hypertension (n, %) | 79 (66.9%) | 8 (88.9%) | 71 (65.1%) | 0.145 |
| Lipid disorders (n, %) | 43 (36.4%) | 4 (44.4%) | 39 (35.8%) | 0.604 |
| PCI (n, %) | 46 (39.0%) | 1 (11.1%) | 45 (41.3%) | 0.074 |
| New hemostatic compression device (n, %) | 59 (50.0%) | 1 (11.1%) | 58 (53.2%) | 0.015 |
RAO: Radial artery occlusion; BMI: body mass index; BP: blood pressure; PCI: percutaneous transluminal coronary intervention.
Values are mean ± standard deviation, median (interquartile range), or n (%).